-       Report 
   - May 2025
    -  154 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - May 2025
    -  115 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - May 2025
    -  114 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - January 2025
    -  141 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                 -       Report 
   - December 2024
    -  146 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - July 2025
    -  350 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - June 2025
    -  210 Pages 
    Global
   
   From       €4490EUR$4,995USD£3,937GBP 
                -       Report 
   - January 2025
    -  209 Pages 
    Global
   
   From       €4490EUR$4,995USD£3,937GBP 
                  -       Report 
   - December 2024
    -  150 Pages 
    Global
   
   From       €3018EUR$3,358USD£2,647GBP 
      €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - March 2025
    -  75 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - May 2025
    -  92 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - February 2025
    -  86 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                  -       Report 
   - March 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                  -       Report 
   - March 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
                  -       Report 
   - December 2024
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
      €4359EUR$4,850USD£3,823GBP 
             
          The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured    in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less   Read more